Avid Bioservices Inc (CDMO)

[jessme]

When does this Russell volume/price surge kick in?
When does the DOD contract expire?

Why does Satson have to do a spin off for Cotara?
To advance these efforts, a new spin-off biopharmaceutical company
headed by Dr. Eugene Mechetner will be formed which will focus on commercializing TNT technologies."



In 2008, Stason launched the Brand Division when we acquired exclusive development and commercialization rights to two early phase novel proprietary compounds in the area of oncology. This division within Stason is focused on New Chemical Entities (NCEs) which provide for unmet medical needs. We are dedicated to building our branded product portfolio through internal development, as well as licensing and acquisition. Through our worldwide strategic alliances, these products will be distributed and/or licensed on a worldwide, or territory specific basis.

STASON REASEARCH

Coming Soon...